Diagnostic and therapeutic value of short-term corticosteroid therapy in exacerbation of mustard gas-induced chronic bronchitis

Basic and Clinical Pharmacology and Toxicology

Volumn 97, Issue 5, 2005, Pages 302-305

  Ghanei, Mostafa ^a   Khalili, Ali Reza Hosseini ^a   Arab, Mohamad Javad ^a   Mojtahedzadeh, Mojtaba ^a   Aslani, Jafar ^a   Lessan Pezeshki, Mahbob ^a   Panahi, Yunes ^a   Alaeddini, Farshid ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FLUTICASONE PROPIONATE; MACROLIDE; METHYLPREDNISOLONE; MUSTARD GAS; PREDNISOLONE;

ADULT; ARTICLE; BOLUS INJECTION; CHRONIC BRONCHITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIAGNOSTIC VALUE; DRUG EFFICACY; DRUG PULSE THERAPY; EXPOSURE; HUMAN; IRAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; SPIROMETRY; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ADULT; ANTI-INFLAMMATORY AGENTS; BRONCHITIS, CHRONIC; CHEMICAL WARFARE AGENTS; FEMALE; FORCED EXPIRATORY FLOW RATES; HUMANS; INJECTIONS, INTRAVENOUS; MALE; METHYLPREDNISOLONE; MUSTARD GAS; SPIROMETRY; VITAL CAPACITY;

EID: 27744483106     PISSN: 17427835     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2005.pto_187.x     Document Type: Article

References (24)

1. Albert, R. K., T. R. Martin & S. W. Lewis: Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency. Ann. Intern. Med. 1980, 92, 753-758.
2. American Thoracic Society: Standardization of spirometry - 1987 update. Amer. Rev. Respir. Dis. 1987, 136, 1285-1298.
3. A.T.S. Statement: Standards for the diagnosis and care of patients with COPD. Amer. J. Respir. Crit. Care Med. 1995, 152, S77-S120.
4. Barnes, P. J.: Mechanism of action of glucocorticoids in asthma. Amer. J. Respir. Crit. Care Med. 1996, 154 (Suppl.), 21-27.
5. Barnes, P. J.: Mechanisms in COPD differences from asthma. Chest 2000, 117, 10-14.
6. Bijani, Kh. & A. A. Moghadamnia: Long-term effects of chemical weapons on respiratory tract in Iraq-Iran war victims living in Babol (North of Iran). Ecotoxicol. Environ. Saf. 2002, 53, 422-424.
7. Culpitt, S. V., J. A. Nightingale & P. J. Barnes: Effect of fluticasone propionate on induced sputum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with COPD. Amer. J. Respir. Crit. Care Med. 1999, 160, 1635-1639.
8. Davies, L., R. M. Angus & P. M. A. Calverley: Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomized controlled trial. Lancet 1999, 354, 456-460.
9. Emad, A. & A. Rezaeian: The diversity of the effects of sulfur mustard gas inhalation on respiratory system, 10 years after a single exposure: analysis of 197 cases. Chest 1997, 112, 734-738.
10. Emerman, C. L., A. F. Connors, T. W. Lukens, M. E. May & D. Effron: A randomized controlled trial of methylprednisolone in the emergency treatment of acute exacerbation of COPD. Chest 1989, 95, 563-567.
11. Eliasson, O., J. Hoffman, D. Trueb, D. Frederick & R. McCormick: Corticosteroids in COPD. A clinical trial and reassessment of the literature. Chest 1986, 89, 484-490.
12. Fein, A. & A. M. Fein: Management of acute exacerbations in chronic obstructive pulmonary disease. Curr. Opin. Pulm. Med. 2000, 6, 122-126.
13. Ghanei, M., J. Aslani, Sh. Khateri & K. Hamadani Zadeh: Public health status of civil population of sardasht 15 years following large scale wartime exposure to sulfur mustard. J. Burn Surg. Wound Care 2003, 2, 1-7.
14. Ghanei, M., M. Mokhtari, M. Mir Mohammad & J. Aslani: Bronchiolitis obliterans following exposure to sulfur mustard: chest high resolution computed tomography. Eur. Radiol. 2004, 52, 164-169.
15. Hosseini, K., S. Alavi & A. R. Abedi: Reversibility of airflow obstruction in chronic obstructive pulmonary disease secondary to sulfur mustard gas injury. Arch. Iranian Med. 1999, 2, 178-180.
16. Keatings, V. M., A. Jatakanon, Y. M. Worsdell et al: Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Amer. J. Respir. Crit. Care Med. 1997, 155, 542-548.
17. Khateri, S., M. Ghanei, S. Keshavarz, M. Soroush & D. Haines: Incidence of lung, eye and skin lesions on late complications in 34000 Iranian with wartime exposure to mustard agent. J. Occup. Environ. Med. 2003, 45, 1136-1143.
18. Murata, G. H., M. S. Gorby, T. W. Chick & A. K. Halperin: Intravenous and oral corticosteroids for the prevention of relapse after treatment of decompensated COPD. Chest 1990, 98, 845-849.
19. Nefedov, V. B. & E. A. Shergina: Role of bronchospasm in development of bronchial obstruction in chronic bronchitis. Ter Arkh 2000, 72, 57-59.
20. Niewoehner, D. E., M. L. Erbland, R. H. Deupree et al.: Effect of systemic glucocorticoids on exacerbation of chronic obstructive pulmonary disease. New Engl. J. Med. 1999, 340, 1941-1947.
21. Pauwels, R. A., A. S. Buist, P. M. A. Cleverly, C. R. Jenkins & S. S. Hurd: NHLBI /WHO Global initiative for chronic obstructive lung disease (GOLD)Workshop summary. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Amer. J. Respir. Crit. Care Med. 2001, 163, 1256-1276.
22. Sohrabpour, H. & M. Maleki: Air way hyperactivity in mustard gas victims with normal spirometry. Proceeding of the Sixth Annual Congress on Chronic Complications of Mustard Gas. Tehran, Iran, 1988, abstract no. 10.
23. Thomason, J. W. W., T. W. Rice & A. P. Milstone: Bronchiolitis obliterans in a survivor of chemical weapons attack. JAMA 2003, 290, 598-599.
24. U.N. Report of specialists appointed by the secretary general to investigate allegations by the Islamic Republic of Iran concerning the use of chemical weapons. New York Security Council of United Nations document S/16433/1986.